Clinical Interventions

Individuals with mental illness and addiction comprise at least half of the patients in most mental health treatment systems. This combination results in increased risk for frequent psychiatric relapses, poor medication compliance, violence, suicide, legal problems, and high utilization of the emergency room or inpatient services. Traditional mental health and addiction treatments have not adequately addressed these co-occurring disorders due to clinical interventions, programs, and system flaws that have not addressed the individual's needs. Integrated treatment requires both an understanding of mental illness and addiction and the means to integrate and modify the traditional treatment approaches in both the mental health and addiction treatment fields. There is strong evidence to support the efficacy and effectiveness of integrated treatment in this population. All mental health clinicians should become experienced and skilled in the core psychotherapy approaches to treating substance use disorders, including motivational enhancement therapy, relapse prevention, and 12-step facilitation. In addition, integrated treatment includes integrating medications for both addiction and mental illness with the behavioral therapies and other psychosocial interventions.

Recent clinical studies have shown that between 30% and 60% of drug abusers have mental health diagnoses Depression, Schizophrenia, and Manic illness disorders. Drug Addiction is a typical of disorder involves the interaction of environmental factors and genetic factors to increase the susceptibility of an individual to addictive behaviour. SAMHA scientists are working on the pharmacological and neuropsychosocial models and approaches that involve preclinical studies and clinical findings, to explain the effects of mental health and physical disorders and outcomes in addicted persons. Researchers focus on pregnant women smokes cigarettes. Tobacco usage elevates therapeutic and behavioural therapies in smokers with concurrent psychiatric disorders. Scientists are developing interventions using pharmacological and behavioural treatments in alcohol and chemical dependence. The overall goal of the research is to participate and conduct high-quality multi-site clinical trials for drug abuse and addiction, for the development, and adoption of effective approaches in this field.

  • Mental Health
  • Emotional health
  • Behavioral health sciences
  • Spiritual sciences
  • Psychology and Education
  • Motivational interviewing
  • Contingency management
  • Residential treatment
  • Psychodynamic therapy
  • Dialectical behavioral therapy
  • Cognitive impairment

Related Conference of Clinical Interventions

July 16-18, 2018

7th World Congress on Addictive Disorders & Addiction Therapy

London, UK

Venue: Park Inn by Radisson Hotel & Conference Centre London, UK
July 16-17, 2018

25th World Congress on Neurology and Neurodisorders

Melbourne, Australia
July 23-25, 2018

11th International Conference on Vascular Dementia

Moscow, Russia
July 23 - 25, 2018

27th Euro-Global
Neurologists Meeting

Moscow, Russia
August 06-08, 2018

26th European Neurology Congress

Madrid, Spain
August 29-30, 2018

4th World Congress on Parkinsons & Huntington Disease

Zurich, Switzerland
August 29-30, 2018

4th International Conference on Epilepsy & Treatment

Zurich, Switzerland
August 31-September 01, 2018

World Summit on

Heart, Stroke & Neurological Disorders

Boston, Massachusetts, USA
August 31-September 01, 2018

14th World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness

Boston, Massachusetts, USA
September 05-06, 2018

4th Global Congress on Spine and Spinal Disorders

Auckland, New Zealand
September 10-12, 2018

International Conference on

Dublin, Ireland
September 13-15, 2018

6th International Conference on Brain Disorders and Therapeutics

Copenhagen, Denmark
September 19-20, 2018

18th Global Neuroscience Conference

Tokyo, Japan
September, 20-22

International Conference on Neurology & Health Care

Lisbon, Portugal
September 20-21, 2018

Annual Congress on Neurology & Neuroscience

Prague, Czech Republic
September 20-21, 2018

8th International Congress on Stroke and Brain Hemorrhage

Prague | Czech Republic
September 21-22, 2018

8th International Conference on Neurology and Brain Disorders

Philadelphia, Pennsylvania, USA
September 21-22, 2018

3rd International Conference on Neuropsychiatry and Sleep Medicine

Philadelphia, Pennsylvania, USA
September 26-27, 2018

28th World Summit on Neurology, Neuroscience and Neuropharmacology

Montreal, Quebec, Canada
October 11-13, 2018

25th Cognitive Neuroscience Congress

Dubai, UAE
November 1-2, 2018

4th International Conference on Spine Surgery

Brussels, Belgium

November 12-13, 2018

5th Annual Conference on Stroke and Neurological Disorders

Istanbul, Turkey
November 12-13, 2018

4th International Conference on Spine and Spinal Disorders

Berlin, Germany
November 12-13, 2018

International conference on Dual Diagnosis and Disorders

Melbourne, Australia
November 12-13, 2018

30th International Conference on Mental and Behavioral Health

Melbourne, Australia
November 16-17, 2018

4th World Congress on Epilepsy and Treatment

Tokyo, Japan
March 18-20, 2019

World Depression Congress

Dubai, UAE
November 22-23, 2018

World Congress on Epilepsy and Brain Disorders

Cape Town, South Africa
November 26-28, 2018

World Neuron Congress

Helsinki, Finland
December 5-7, 2018

World Brain Congress

Dubai, UAE
December 13-15, 2018

13th Annual Conference on Dementia and Alzheimers Disease

Abu Dhabi, UAE
February 15-16, 2019

11th International Conference on Vascular Dementia

Amsterdam| Netherlands
February 28 – March 02, 2019

28th World Congress on Neurology and Therapeutics

Berlin, Germany
March 20-21, 2019

11th World Congress on Alzheimers Disease & Dementia

Sydney, Australia
March 25-26, 2019

8th International Conference on Psychoneuroimmunology

Bucharest, Romania

Clinical Interventions Conference Speakers